Perspective Therapeutics Inc
CATX3.730USD
+0.050+1.36%
交易中 （美東）報價延遲15分鐘
276.21M總市值
虧損本益比TTM
關於 Perspective Therapeutics Inc 公司
Perspective Therapeutics, Inc. 是一家放射性藥物開發公司，正在開發針對全身癌症的先進治療應用。該公司擁有專有技術，利用發射α同位素212Pb通過專門的靶向肽向癌細胞提供強大的輻射。該公司還在開發結合相同靶向肽的成像診斷技術，這爲個性化治療和優化患者結果提供了機會。這種治療診斷方法能夠看到特定的腫瘤，然後對其進行治療，從而有可能提高療效並最大限度地降低毒性。該公司的黑色素瘤 (VMT01) 和神經內分泌腫瘤 (VMT-α-NET) 項目已進入 I/IIa 期成像和治療試驗，用於治療轉移性黑色素瘤和神經內分泌腫瘤，試驗地點在幾所學術機構。該公司還開發了 212Pb 發生器，以確保臨牀試驗和商業運營的關鍵同位素。
公司簡介
公司代碼CATX
公司名稱Perspective Therapeutics Inc
上市日期May 31, 2002
CEOMr. Johan M. (Thijs) Spoor
員工數量138
證券類型Ordinary Share
年結日May 31
公司地址2401 Elliott Avenue
城市SEATTLE
上市交易所NYSE American Consolidated
國家United States of America
郵編98121
電話12066760900
網址https://www.perspectivetherapeutics.com/
公司代碼CATX
上市日期May 31, 2002
CEOMr. Johan M. (Thijs) Spoor
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Markus Puhlmann, M.D.
Dr. Markus Puhlmann, M.D.
Chief Medical Officer
Chief Medical Officer
137.54K
--
Mr. Johan M. (Thijs) Spoor
Mr. Johan M. (Thijs) Spoor
Chief Executive Officer, Director
Chief Executive Officer, Director
87.68K
+72.66%
Mr. Jonathan Robert Hunt
Mr. Jonathan Robert Hunt
Chief Accounting Officer
Chief Accounting Officer
48.80K
--
Mr. Juan Graham
Mr. Juan Graham
Chief Financial Officer
Chief Financial Officer
35.35K
+1649.33%
Ms. Heidi Henson, CPA
Ms. Heidi Henson, CPA
Independent Director
Independent Director
25.98K
--
Dr. Frank Morich, M.D., Ph.D.
Dr. Frank Morich, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Robert Froman Williamson, III
Mr. Robert Froman Williamson, III
Independent Director
Independent Director
--
--
Ms. Lori A. Woods
Ms. Lori A. Woods
Chairman of the Board
Chairman of the Board
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Markus Puhlmann, M.D.
Dr. Markus Puhlmann, M.D.
Chief Medical Officer
Chief Medical Officer
137.54K
--
Mr. Johan M. (Thijs) Spoor
Mr. Johan M. (Thijs) Spoor
Chief Executive Officer, Director
Chief Executive Officer, Director
87.68K
+72.66%
Mr. Jonathan Robert Hunt
Mr. Jonathan Robert Hunt
Chief Accounting Officer
Chief Accounting Officer
48.80K
--
Mr. Juan Graham
Mr. Juan Graham
Chief Financial Officer
Chief Financial Officer
35.35K
+1649.33%
Ms. Heidi Henson, CPA
Ms. Heidi Henson, CPA
Independent Director
Independent Director
25.98K
--
Dr. Frank Morich, M.D., Ph.D.
Dr. Frank Morich, M.D., Ph.D.
Independent Director
Independent Director
--
--
收入明細
FY2025Q1
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
暫無數據
地區USD
名稱
營收
佔比
United States
342.00K
0.00%
業務
地區
暫無數據
股東統計
更新時間: 5月17日 週六
更新時間: 5月17日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Lantheus Holdings, Inc.
15.73%
Fidelity Management & Research Company LLC
10.58%
BlackRock Institutional Trust Company, N.A.
4.98%
The Vanguard Group, Inc.
4.13%
Deerfield Management Company, L.P.
3.81%
Other
60.76%
持股股東
持股股東
佔比
Lantheus Holdings, Inc.
15.73%
Fidelity Management & Research Company LLC
10.58%
BlackRock Institutional Trust Company, N.A.
4.98%
The Vanguard Group, Inc.
4.13%
Deerfield Management Company, L.P.
3.81%
Other
60.76%
股東類型
持股股東
佔比
Investment Advisor
32.07%
Hedge Fund
17.16%
Corporation
15.73%
Investment Advisor/Hedge Fund
6.89%
Research Firm
3.49%
Individual Investor
3.14%
Bank and Trust
1.48%
Pension Fund
0.08%
Insurance Company
0.02%
Other
19.93%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
302
59.45M
80.09%
-11.86M
2025Q1
304
60.05M
85.30%
-5.99M
2024Q4
290
62.49M
92.46%
-2.78M
2024Q3
266
63.29M
93.81%
+14.81M
2024Q2
218
52.68M
78.08%
+17.83M
2024Q1
143
38.70M
62.94%
+26.72M
2023Q4
99
10.58M
37.69%
+4.15M
2023Q3
101
10.50M
37.42%
+4.44M
2023Q2
99
3.54M
12.59%
+269.05K
2023Q1
108
3.01M
11.39%
+817.81K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Lantheus Holdings, Inc.
11.68M
15.73%
--
--
Apr 02, 2025
Fidelity Management & Research Company LLC
7.86M
10.58%
+72.66K
+0.93%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.70M
4.98%
-33.85K
-0.91%
Mar 31, 2025
The Vanguard Group, Inc.
3.07M
4.13%
-65.21K
-2.08%
Mar 31, 2025
Deerfield Management Company, L.P.
2.83M
3.81%
-109.34K
-3.72%
Mar 31, 2025
Octagon Capital Advisors LP
2.25M
3.03%
-54.75K
-2.38%
Mar 31, 2025
Affinity Asset Advisors LLC
2.22M
3%
+924.20K
+71.09%
Mar 31, 2025
Avidity Partners Management LP
2.20M
2.96%
-497.33K
-18.46%
Mar 31, 2025
Fidelity Institutional Asset Management
2.20M
2.96%
-49.22K
-2.19%
Mar 31, 2025
Nicholson Wealth Management Group, LLC
1.61M
2.17%
--
--
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
Fidelity Fundamental Small-Mid Cap ETF
0.06%
iShares Micro-Cap ETF
0.05%
iShares Russell 2000 Value ETF
0.02%
iShares Biotechnology ETF
0.02%
Proshares Ultra Russell 2000
0.01%
ProShares Hedge Replication ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
ProShares UltraPro Russell2000
0.01%
iShares Russell 2000 ETF
0.01%
Global X Russell 2000 ETF
0.01%
查看更多
Fidelity Fundamental Small-Mid Cap ETF
佔比0.06%
iShares Micro-Cap ETF
佔比0.05%
iShares Russell 2000 Value ETF
佔比0.02%
iShares Biotechnology ETF
佔比0.02%
Proshares Ultra Russell 2000
佔比0.01%
ProShares Hedge Replication ETF
佔比0.01%
Schwab U.S. Small-Cap ETF
佔比0.01%
ProShares UltraPro Russell2000
佔比0.01%
iShares Russell 2000 ETF
佔比0.01%
Global X Russell 2000 ETF
佔比0.01%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Apr 09, 2024
Merger
10<1
Apr 09, 2024
Merger
10<1
Apr 09, 2024
Merger
10<1
Apr 09, 2024
Merger
10<1
公告日期
類型
比率
Apr 09, 2024
Merger
10<1
Apr 09, 2024
Merger
10<1
Apr 09, 2024
Merger
10<1
Apr 09, 2024
Merger
10<1
